125 Shoreway Road, Suite B
San Carlos
California
94070
United States
(650) 226-0120
(650) 631-3731
Related Content
September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial ...
September 26, 2017
September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial ...
September 25, 2017
August 16, 2017 — BioCardia Inc. recently announced completion of treatment for the 10-patient roll-in cohort for the ...
August 16, 2017January 9, 2017 — BioCardia Inc. announced in December the issuance of United States Patent No. 9,517,199 relating to a ...
January 09, 2017January 3, 2017 — BioCardia Inc. announced in December the initiation of the CardiAMP Heart Failure pivotal trial, a ...
January 03, 2017
December 5, 2014 — BioCardia Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s ...
December 05, 2014
December 1, 2014 — BioCardia Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted the ...
December 01, 2014
March 31, 2014 — BioCardia Inc. announced it received CE mark for its Morph AccessPro steerable introducer, designed for ...
March 31, 2014December 12, 2013 — BioCardia Inc., a cardiovascular regenerative medicine company, announced positive 12-month results ...
December 12, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now